Exploring the Protective Effects of Taxifolin in Cardiovascular Health: A Comprehensive Review

Area of Science:

• Pharmacology
• Cardiovascular Medicine
• Natural Products Chemistry

Background:

• Taxifolin is a flavonoid with demonstrated antioxidant and anti-inflammatory properties.
• It exhibits potential therapeutic benefits for cardiovascular diseases like atherosclerosis, myocardial ischemia, and diabetic cardiomyopathy.

Purpose of the Study:

• To review the cardioprotective effects of taxifolin in preclinical models.
• To elucidate the mechanisms underlying taxifolin's cardiovascular benefits.
• To explore the potential interaction between taxifolin and SGLT2 inhibitors in cardiovascular disease management.

Main Methods:

• Review of preclinical studies on taxifolin's effects in models of atherosclerosis, ischemia/reperfusion injury, and diabetic cardiomyopathy.
• Analysis of molecular mechanisms including PI3K/AKT and JAK2/STAT3 pathways, NADPH oxidase inhibition, and nitric oxide modulation.
• Investigation of taxifolin's impact on glucose metabolism and sodium-glucose transporter (SGLT) expression.

Main Results:

• Taxifolin demonstrates significant cardioprotective effects in various preclinical cardiovascular disease models.
• Key mechanisms include modulation of PI3K/AKT and JAK2/STAT3 signaling, reduced oxidative stress via NADPH oxidase inhibition, and enhanced nitric oxide production.
• Taxifolin influences glucose metabolism by modulating SGLT expression, suggesting synergistic potential with SGLT2 inhibitors.

Conclusions:

• Taxifolin possesses multifaceted potential for cardiovascular disease prevention and treatment.
• Understanding its mechanisms and interaction with SGLT2 pathways may offer novel therapeutic strategies.
• Further clinical studies are warranted to validate taxifolin's efficacy and guide its application in cardiovascular therapies.